Kennedy Van der Laan and Monard Law advised Blau Farmacêutica on the investment.Blau Farmacêutica, a prominent player in the pharmaceutical industry in the United States and…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
